We are live on ! Find out more
UL

Ulys LLC Portfolio holdings

AUM $25.4M
1-Year Est. Return 201.03%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
–
AUM
$64.7M
AUM Growth
–
Cap. Flow
+$64.7M
Cap. Flow %
100.01%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$64.7M
2
CERE
CERES, INC. COMMON STOCK NEW
CERE
+$81.1K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$1.04B
$64.6M 99.85%
+4,254,658
New +$64.7M
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$97K 0.15%
+3,891
New +$81.1K

Similar funds

WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
AGEC
Ark Global Emerging Companies Salt Lake City, Utah $14M AUM
OHS
Odey Holdings (Switzerland) Zurich, Switzerland, Switzerland $11.1M AUM 64.12% 1-Year Est. Return
LW
LLR Walnut Philadelphia, Pennsylvania $10M AUM 71.21% 1-Year Est. Return
PCG
Park Capital Group Redondo Beach, California $8.62M AUM
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM

Ulys LLC's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Ulys LLC, which disclosed 2 positions worth $64.7M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Lexicon Pharmaceuticals: 4,254,658 shares worth $64.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ulys LLC's largest Q2 2013 buy was Lexicon Pharmaceuticals: 4,254,658 shares worth $64.6M.
  • Ulys LLC's ten largest holdings make up 100% of its $64.7M portfolio in Q2 2013.
  • Ulys LLC disclosed 2 positions in Q2 2013, its first 13F filing on record.

Based on Ulys LLC's 13F filing for Q2 2013, filed 9 Aug 2013.